Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Robinhoods quarterly resultsrecord revenue that fell short of expectations, with weaker crypto activity and lower GAAP earningstriggered a post-earnings selloff. Traders are divided between calling the reaction an overreaction and buying the dip on growth in options, prediction markets and subscriptions, versus citing crypto weakness, profit pressure and valuation concerns.

Seagates strong quarterly results and raised outlook have been overshadowed by a sharp post-earnings selloff, with traders debating whether high expectations, profit-taking, and slower margin growth explain the reaction. Many bullish traders view the drop as excessive given robust AI-related storage demand, while others question the stocks valuation and the durability of the growth cycle.

SK Hynixs record quarterly results, AI-driven memory demand and announced shareholder returns are driving attention, with traders pointing to capacity booked through 2029 and shortages potentially lasting into 2030. The reaction is broadly bullish, though some question the muted share response and warn that strong memory earnings may be cyclical or already priced in.

Attention centers on the anticipated completion of Compass Pathways rolling NDA for COMP360, its investigational psilocybin treatment for treatment-resistant depression, and the potential for an accelerated FDA review. Many traders are bullish on approval and commercialization prospects, while others point to the still-pending filing, volatile shares and broader biotech weakness as reasons for caution.

Concerns about Coinbases upcoming earnings and slowing crypto trading activity dominate discussion, alongside volatile Bitcoin markets and COINs perceived underperformance relative to crypto and broader stocks. Bearish traders worry lower activity could pressure results, while some holders expect a positive earnings surprise or a rebound as sentiment and positioning turn pessimistic.

Attention is centered on Teladocs approaching Q3 earnings, with traders looking for evidence that BetterHelps decline is stabilizing and its shift toward insurance can support growth. Bulls speculate that high short interest could amplify a positive reaction, while bears cite weak execution, management credibility, and uncertainty about a path to revenue growth and profitability.

Anthropics IPO filing and bank-backed financing for Broadcom AI chips, alongside a D.A. Davidson upgrade, have renewed focus on AVGOs custom-chip demand outlook. Bulls see stronger demand visibility, while skeptics question the financing structure and Broadcoms exposure if AI spending disappoints; some also say the shares have struggled to hold gains.

Bitcoins sharp pullback is driving attention to Strategys exposure as a leveraged bitcoin-treasury company, with bears warning that weak BTC and ongoing dilution, preferred-stock costs, and debt could pressure MSTR. Bulls counter that the selloff is a buying opportunity and point to a potential rebound around earnings, leaving sentiment sharply divided.

CADL is drawing attention as investors look ahead to the planned BLA submission for CAN-2409, following positive Phase 3 results in localized prostate cancer, alongside anticipated pipeline data. The sharp share-price pullback has divided traders: bulls focus on the clinical results and regulatory milestone, while bears cite CEO share sales, possible dilution, and weakness across small-cap biotech.

Critical Metals European Lithium acquisition becoming legally effective is driving attention, with traders cheering the deal while debating the new-share issuance and possible dilution. High reported short interest and borrowing costs have also fueled squeeze speculation, though some traders caution that the merger shares could add selling pressure.